In response to Acugo\u00ae production being partly shouldered by Minaris\u2019 U.S. plant closure, upstream processes are migrated to the domestic Yokohama plant to establish an integrated manufacturing system. Diversification is pursued to stabilize supply and prepare for future U.S. expansion and adaptation. No impact on current-period results.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4592","jir_company_name":"SBI Bio Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-31","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4592-20260831-01.pdf","jir_short_summary":"In response to Acugo\u00ae production being partly shouldered by Minaris\u2019 U.S. plant closure, upstream processes are migrated to the domestic Yokohama plant to establish an integrated manufacturing system. Diversification is pursued to stabilize supply and prepare for future U.S. expansion and adaptation. No impact on current-period results.","jir_summary":"### Overview\nSunBio plans to close Minaris\u2019 U.S. Mountain View plant, which partly manufactures Acugo\u00ae, and migrate upstream processes to SunBio Japan Minaris Yokohama Plant to build an integrated domestic manufacturing system. This is expected to enhance manufacturing management unity, stabilize supply, and improve efficiency. Domestic inventories are already secured, and there is no expected supply disruption during the migration. In addition, we will advance diversification through a manufacturing outsourcing agreement with JCR Pharma Corporation to strengthen a stable supply framework.\n\n### Impact and Outlook\nThe domestic integration aims to avoid short-term supply disruption while enhancing production capacity to support future U.S. expansion and expansion of brain infarction indications. When disclosed, further information will be provided promptly. FX information is disclosed, but specific financial impact data are not provided in the text.","jir_financial_highlights":"Impact level: Unknown (Unknown)","jir_category":"","jir_hashtags":"","jir_key_figures":"Strengthening of upstream production framework through domestic integration of Acugo\u00ae (migration of upstream processes to Yokohama Plant)\nMigration plan due to Minaris\u2019 U.S. plant closure\nStabilization of supply through diversification with JCR Pharma","jir_meta_title":"SunBio: Notice of Domestic Integration Following U.S. Plant Closure | 2026","jir_meta_description":"SunBio will migrate upstream processes of Acugo\u00ae to the Yokohama Plant of Nihon Minaris in response to Minaris\u2019 U.S. Mountain View plant closure, implementing domestic integration. Explains efforts to stabilize supply and future outlook.","jir_og_title":"SunBio Advances Domestic Integration of Acugo\u00ae Production to Stabilize Supply","jir_og_description":"Taking the closure of Minaris\u2019 U.S. plant as a trigger, SunBio migrates upstream processes to the Yokohama Plant to build a domestic integrated manufacturing system. Diversification strengthens stable supply.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9416,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"corporate_restructuring","footnotes":""},"sector":[],"importance":[],"class_list":["post-108657","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n